A drug commonly used to prevent organ transplant rejection increased blood flow in the brains of healthy middle-aged adults who carry a genetic variant linked to a higher risk of Alzheimer’s disease, according to a new University of Missouri study.

Why you should care:

The findings could help researchers identify ways to delay or prevent Alzheimer’s disease in people who are genetically predisposed to developing the condition.